These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7511313)

  • 21. [Antibiotics can ameliorate circulatory complications of liver cirrhosis].
    Madsen BS; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal hypertension: state of the art.
    Gatta A; Sacerdoti D; Bolognesi M; Merkel C
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of the hyperdynamic syndrome in cirrhosis.
    Licata A; Mazzola A; Ingrassia D; Calvaruso V; Cammà C; Craxì A
    Eur J Intern Med; 2014 Nov; 25(9):795-802. PubMed ID: 25245607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1108-11. PubMed ID: 11776147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of circulatory dysfunction in cirrhotic portal hypertension.
    Ho HL; Huang HC
    J Chin Med Assoc; 2015 Apr; 78(4):195-203. PubMed ID: 25769934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nitric oxide in portal hypertensive systemic and portal vascular pathology.
    Hartleb M; Michielsen PP; Dziurkowska-Marek A
    Acta Gastroenterol Belg; 1997; 60(3):222-32. PubMed ID: 9396180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis.
    Lo Iacono O; Rincón D; Hernando A; Ripoll C; Catalina MV; Salcedo M; Clemente G; Gomez J; Nuñez O; Matilla A; Bañares R
    Liver Int; 2008 Sep; 28(8):1129-35. PubMed ID: 18482273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology of portal hypertension and mechanisms of sodium and water retention in cirrhosis].
    Garini G; Delsante M; Iannuzzella F
    Recenti Prog Med; 2011 Mar; 102(3):134-40. PubMed ID: 21572486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension.
    Kawanaka H; Akahoshi T; Kinjo N; Iguchi T; Ninomiya M; Yamashita YI; Ikegami T; Yoshizumi T; Shirabe K; Maehara Y
    Br J Surg; 2014 Nov; 101(12):1585-93. PubMed ID: 25200126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous blood pressure monitoring in cirrhosis. Relations to splanchnic and systemic haemodynamics.
    Møller S; Christensen E; Henriksen JH
    J Hepatol; 1997 Aug; 27(2):284-94. PubMed ID: 9288602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
    Albornoz L; Bandi JC; de las Heras M; Mastai R
    Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.